Breast cancer, HR+/HER2- early-stage

Clinical trials for Breast cancer, HR+/HER2- early-stage explained in plain language.

Never miss a new study

Get alerted when new Breast cancer, HR+/HER2- early-stage trials appear

Sign up with your email to follow new studies for Breast cancer, HR+/HER2- early-stage, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Can a new calculator better predict breast cancer return?

Knowledge-focused Not yet recruiting

This study aims to create a simple tool (called a nomogram) that predicts the chance of breast cancer coming back in women with HR+/HER2- early-stage breast cancer. Researchers will look back at the records of 500 patients to find patterns that help personalize risk estimates. Th…

Matched conditions: BREAST CANCER, HR+/HER2- EARLY-STAGE

Sponsor: Shengjing Hospital • Aim: Knowledge-focused

Last updated Jun 27, 2026 11:04 UTC

Breast cancer, HR+/HER2- early-stage

Get alerted when new Breast cancer, HR+/HER2- early-stage trials appear

Can a new calculator better predict breast cancer return?